Work

Novel agents for chronic myeloid leukemia: from imatinib to dasatinib and nilotinib: overcoming resistance

Year: 2006

Type: article

Source: Community Oncology

DOI: 10.1016/s1548-5315(11)70745-8

Author: Michael W.N. Deininger

Institution: Oregon Health & Science University

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1969597724

FWCI:

Cites: 35

Cited by: 1

Related to: 10